Treat early, treat appropriately.
The treatment of type 2 diabetes is shifting from secondary specialist centres to the primary care setting. However, for this shift to be sustainable and successful, primary care physicians (PCPs) must effectively provide aspects of diabetes care traditionally supplied by specialists. In particular, the early and appropriate use of insulin in type 2 diabetes will increasingly become the responsibility of PCPs. This review examines how patients with type 2 diabetes are currently managed across several European countries, and explores the evidence around insulin use in type 2 diabetes and the implications for primary care.
Liebl
Andreas
A
Center for Diabetes and Metabolism, Fachklinik, Bad Heilbrunn, Germany. andreas.liebl@fachklinik-bad-heilbrunn.de <andreas.liebl@fachklinik-bad-heilbrunn.de>
Rutten
Guy
G
Abraira
Carlos
C
D000465:Algorithms; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005060:Europe; D019317:Evidence-Based Medicine; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D011320:Primary Health Care / Q000379:methods*
D007004:Hypoglycemic Agents